Rhythm Pharmaceuticals (RYTM) had the highest return between June 6, 2022 and July 30, 2022 by a mid-cap US stock, returning 240.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 6/6/2022 - 7/30/2022 | 240.54% |
New Oriental Education & Technology (EDU) | 6/6/2022 - 7/30/2022 | 100.51% |
Impinj (PI) | 6/6/2022 - 7/30/2022 | 68.69% |
Nuvalent (NUVL) | 6/6/2022 - 7/30/2022 | 60.82% |
Wingstop (WING) | 6/6/2022 - 7/30/2022 | 59.94% |
Arcellx (ACLX) | 6/6/2022 - 7/30/2022 | 55.86% |
Privia Health (PRVA) | 6/6/2022 - 7/30/2022 | 49.57% |
Veracyte (VCYT) | 6/6/2022 - 7/30/2022 | 48.98% |
Axsome Therapeutics (AXSM) | 6/6/2022 - 7/30/2022 | 47.12% |
Calix (CALX) | 6/6/2022 - 7/30/2022 | 46.82% |
PTC Therapeutics (PTCT) | 6/6/2022 - 7/30/2022 | 45.22% |
Nuscale Power (SMR) | 6/6/2022 - 7/30/2022 | 44.99% |
TransMedics (TMDX) | 6/6/2022 - 7/30/2022 | 40.75% |
SpringWorks Therapeutics (SWTX) | 6/6/2022 - 7/30/2022 | 38.98% |
Catalyst Pharmaceuticals (CPRX) | 6/6/2022 - 7/30/2022 | 38.19% |
TG Therapeutics (TGTX) | 6/6/2022 - 7/30/2022 | 37.39% |
Gitlab (GTLB) | 6/6/2022 - 7/30/2022 | 35.86% |
Scholar Rock (SRRK) | 6/6/2022 - 7/30/2022 | 34.77% |
Enphase Energy (ENPH) | 6/6/2022 - 7/30/2022 | 34.68% |
Corcept Therapeutics (CORT) | 6/6/2022 - 7/30/2022 | 34.11% |
Zai Lab (ZLAB) | 6/6/2022 - 7/30/2022 | 33.81% |
Alignment Healthcare LLC (ALHC) | 6/6/2022 - 7/30/2022 | 32.37% |
HUTCHMED DRC (HCM) | 6/6/2022 - 7/30/2022 | 30.7% |
Extreme Networks (EXTR) | 6/6/2022 - 7/30/2022 | 29.5% |
Guardant Health (GH) | 6/6/2022 - 7/30/2022 | 28.74% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
